IL103238A - תכשירי אירוסול לחוצים - Google Patents

תכשירי אירוסול לחוצים

Info

Publication number
IL103238A
IL103238A IL10323892A IL10323892A IL103238A IL 103238 A IL103238 A IL 103238A IL 10323892 A IL10323892 A IL 10323892A IL 10323892 A IL10323892 A IL 10323892A IL 103238 A IL103238 A IL 103238A
Authority
IL
Israel
Prior art keywords
polymer
composition according
units
pvp
propellant
Prior art date
Application number
IL10323892A
Other languages
English (en)
Other versions
IL103238A0 (en
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27450754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL103238(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919120396A external-priority patent/GB9120396D0/en
Priority claimed from GB919120675A external-priority patent/GB9120675D0/en
Priority claimed from GB919124661A external-priority patent/GB9124661D0/en
Priority claimed from GB929203212A external-priority patent/GB9203212D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of IL103238A0 publication Critical patent/IL103238A0/xx
Publication of IL103238A publication Critical patent/IL103238A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10323892A 1991-09-25 1992-09-22 תכשירי אירוסול לחוצים IL103238A (he)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919120396A GB9120396D0 (en) 1991-09-25 1991-09-25 Formulations
GB919120675A GB9120675D0 (en) 1991-09-28 1991-09-28 Formulation
GB919124661A GB9124661D0 (en) 1991-11-19 1991-11-19 Formulations
GB929203212A GB9203212D0 (en) 1992-02-14 1992-02-14 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
IL103238A0 IL103238A0 (en) 1993-02-21
IL103238A true IL103238A (he) 1995-07-31

Family

ID=27450754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10323892A IL103238A (he) 1991-09-25 1992-09-22 תכשירי אירוסול לחוצים

Country Status (29)

Country Link
US (1) US6641800B1 (he)
EP (2) EP0534731A1 (he)
JP (1) JP3142136B2 (he)
KR (1) KR100275426B1 (he)
CN (1) CN1050285C (he)
AT (1) ATE132739T1 (he)
AU (1) AU654397B2 (he)
BG (1) BG61752B1 (he)
BR (1) BR9206549A (he)
CA (1) CA2119932C (he)
CZ (1) CZ282506B6 (he)
DE (1) DE69207606T3 (he)
DK (1) DK0605578T4 (he)
ES (1) ES2082507T5 (he)
FI (1) FI110407B (he)
GR (2) GR3019098T3 (he)
HK (1) HK1005564A1 (he)
HU (2) HUT67480A (he)
IL (1) IL103238A (he)
MX (1) MX9205483A (he)
MY (1) MY108309A (he)
NO (1) NO307124B1 (he)
NZ (1) NZ244439A (he)
RO (1) RO114735B1 (he)
RU (1) RU2122852C1 (he)
SK (1) SK279456B6 (he)
TW (1) TW216442B (he)
UA (1) UA41873C2 (he)
WO (1) WO1993005765A1 (he)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
GB9214819D0 (en) * 1992-07-13 1992-08-26 Minnesota Mining & Mfg Valve assemblies
EP0689423B1 (en) * 1993-03-17 1997-09-17 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
KR100392280B1 (ko) 1995-06-27 2003-11-19 베링거 인겔하임 카게 추진제비함유흡입성에어로졸을제조하기위한안정한추진제비함유약제학적용액
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US20030026766A1 (en) * 2000-04-13 2003-02-06 Mark Sanders Medicaments for treating respiratory disorders comprising formoterol and fluticasone
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
SK286694B6 (sk) 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
US7544177B2 (en) * 2002-01-24 2009-06-09 The Regents Of The University Of California Aerosol device to deliver bioactive agent
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) * 2003-12-10 2004-01-14 Medpharm Ltd Metered dose inhalation preparations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
WO2005089738A2 (en) * 2004-03-17 2005-09-29 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
US20070031343A1 (en) * 2005-08-04 2007-02-08 Bonfour Charles A Iii Flavored medicinal inhalant
FR2895260B1 (fr) * 2005-12-23 2009-02-20 Servier Lab Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2274039A2 (en) 2008-05-06 2011-01-19 Wilson-Cook Medical Inc. Apparatus and methods for delivering therapeutic agents
KR20110096538A (ko) * 2008-11-04 2011-08-30 씨아이피엘에이 엘티디. 약제학적 에어로졸 조성물
CA2747390C (en) 2008-12-23 2016-10-04 Wilson-Cook Medical Inc. Apparatus and methods for containing and delivering therapeutic agents
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
GB201402513D0 (en) * 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
EP3364943B1 (de) * 2015-10-23 2021-06-23 Basf Se Formulierungen mit kontrollierter freisetzung von geruchsstoffen zur dermalen anwendung
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US417295A (en) * 1889-12-17 Fabriken
AT274245B (de) 1967-05-17 1969-09-10 Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en) 1972-09-06 1977-05-24 Burroughs Wellcome Co. Cyclic sulphur compounds
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
EP0175671A1 (de) 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3775960D1 (de) * 1986-03-10 1992-02-27 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
ATE60226T1 (de) 1986-03-10 1991-02-15 Kurt Burghart Pharmazeutikum sowie verfahren zu seiner herstellung.
US4752466A (en) 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL95952A0 (en) 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
US5658549A (en) 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery

Also Published As

Publication number Publication date
JP3142136B2 (ja) 2001-03-07
EP0605578B1 (en) 1996-01-10
FI941388A (fi) 1994-03-25
GR3019098T3 (en) 1996-05-31
SK34094A3 (en) 1994-11-09
EP0605578B2 (en) 1999-09-22
CZ282506B6 (cs) 1997-07-16
CZ69594A3 (en) 1995-11-15
CA2119932C (en) 2002-05-21
HU210818A9 (en) 1995-08-28
DE69207606D1 (de) 1996-02-22
MY108309A (en) 1996-09-30
NZ244439A (en) 1994-01-26
RO114735B1 (ro) 1999-07-30
DK0605578T3 (da) 1996-03-25
CN1050285C (zh) 2000-03-15
UA41873C2 (uk) 2001-10-15
NO941077D0 (no) 1994-03-24
NO307124B1 (no) 2000-02-14
ES2082507T3 (es) 1996-03-16
GR3032103T3 (en) 2000-03-31
RU2122852C1 (ru) 1998-12-10
JPH07502262A (ja) 1995-03-09
CA2119932A1 (en) 1993-04-01
ATE132739T1 (de) 1996-01-15
MX9205483A (es) 1993-05-01
FI110407B (fi) 2003-01-31
BR9206549A (pt) 1995-10-17
HUT67480A (en) 1995-04-28
CN1071832A (zh) 1993-05-12
FI941388A0 (fi) 1994-03-25
EP0605578A1 (en) 1994-07-13
HK1005564A1 (en) 1999-01-15
KR100275426B1 (ko) 2001-03-02
ES2082507T5 (es) 1999-11-16
TW216442B (en) 1993-11-21
HU9400853D0 (en) 1994-06-28
SK279456B6 (sk) 1998-11-04
DK0605578T4 (da) 2000-03-06
AU2647192A (en) 1993-04-27
US6641800B1 (en) 2003-11-04
NO941077L (no) 1994-05-18
WO1993005765A1 (en) 1993-04-01
AU654397B2 (en) 1994-11-03
DE69207606T2 (de) 1996-06-27
EP0534731A1 (en) 1993-03-31
IL103238A0 (en) 1993-02-21
BG98681A (bg) 1995-02-28
DE69207606T3 (de) 2000-03-16
BG61752B1 (bg) 1998-05-29

Similar Documents

Publication Publication Date Title
EP0605578B2 (en) Pressurised aerosol compositions
US6123924A (en) Pressurized aerosol inhalation compositions
CA2085884C (en) Pressurized hydrofluorocarbon aerosol compositions
US6461591B1 (en) Medical aerosol formulations
EP1275375B1 (en) Process for the preparation of aerosol compositions
CA2074495C (en) Propellant compositions
JPH07502275A (ja) 懸濁エアゾール製剤
SK140493A3 (en) Non-chlorofluorocarbon aerosol formulations
SK285246B6 (sk) Tlakové inhalátory s odmeranou dávkou a stabilný aerosólový prípravok na použitie do tlakových inhalátorov
CA2195874A1 (en) Aerosol drug formulations containing polyglycolyzed glycerides
EP1684721A2 (en) Aerosol formulations comprising a carboxylic acid surfactant
SA92130289B1 (ar) تركيبات ايروسول aerosol مضغوط
IL98666A (he) תכשירי אירוסול בלחץ
SK278930B6 (sk) Antiastmatický aerosolový prípravok

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired